Approvals and flops in drug development in 2023 by Giuliana Miglierini Approvals and flops in drug development in 2023 The European Medicines Agency published its annual…
The new MHRA’s framework for clinical studies By Giuliana Miglierini The repositioning of the United Kingdom as a global leader for clinical development of medicinal…